Healthcare / Medical Care FacilitiesBSE
$40.90
+0.00 (+0.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 33% · confianza 22%
FCF escenarios
weak_data · normalized FCF $-46.7M · quality 62.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
28/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$278M
P/E
N/A
•EV/EBITDA
28.7x
↑ROE
-4.9%
↓Gross Margin
100.0%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2023–2026 · 3 años de histórico normalizado
Revenue CAGR
+64.5%
FCF CAGR
—
FCF margin
-62.6%
FCF / Net income
9.48x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $94.3M · net income $-6.2M · FCF $-59.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $94.3M | $94.3M | $90.0M | $68.8M | $21.2M |
| Net Income | $-6.2M | $-6.2M | $-3.3M | $6.1M | $2.2M |
| EBITDA | $9.6M | $9.6M | $6.9M | $10.8M | $3.9M |
| EPS | — | — | -0.48 | 1.07 | 0.32 |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Margin | -9.7% | -9.7% | -9.8% | 3.2% | 12.7% |
| Net Margin | -6.6% | -6.6% | -3.6% | 8.8% | 10.3% |
| Balance Sheet | |||||
| Current Ratio | 2.66 | 2.66 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-59.0M | $-59.0M | $-46.7M | $-15.6M | $-8.4M |
| Returns | |||||
| ROE | -4.9% | -4.9% | -2.4% | 4.3% | 4.3% |
| Valuation | |||||
| P/E | — | — | — | 50.47 | — |
| EV/EBITDA | 28.67 | 28.67 | 37.74 | 27.65 | — |
| P/B | 2.18 | 2.18 | 1.96 | 2.17 | — |
| Growth & Yield | |||||
| Revenue Growth | 4.8% | 4.8% | 30.8% | 224.7% | — |
| EPS Growth | — | — | -144.9% | 234.0% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-8.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.48 → n/d
Residual
-8.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.